Thomson Medical Group (FRA:3H5) Other Financing: €-33.6 Mil (TTM As of Dec. 2025)


What is Thomson Medical Group Other Financing?

Thomson Medical Group FRA:3H5 Other Financing is €-33.6 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Thomson Medical Group's Other Financing for the six months ended in Dec. 2025 was €-15.9 Mil.

Thomson Medical Group's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was €-33.6 Mil.

Thomson Medical Group Other Financing Historical Data

* Premium members only.

The historical data trend for Thomson Medical Group's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thomson Medical Group Other Financing Chart

Thomson Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24 Jun25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.18 -15.92 -22.17 -40.29 -39.22

Thomson Medical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.37 -22.94 -22.51 -17.70 -15.86

Thomson Medical Group Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-33.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-33.6 Mil mean?
Thomson Medical Group (FRA:3H5) has a Other Financing of €-33.6 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Thomson Medical Group and its competitors.
Is Thomson Medical Group's Other Financing too high?
Thomson Medical Group's current Other Financing is €-33.6 Mil.
How does Thomson Medical Group's Other Financing compare to HCA and THC?
Thomson Medical Group's Other Financing of €-33.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Thomson Medical Group and its competitors. Thomson Medical Group's current Other Financing is €-33.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Possible Value Trap. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 30% below its estimated fair value. The current Other Financing is €-33.6 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current Other Financing is €-33.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thomson Medical Group Business Description

Other Exchanges A50:Singapore
Address 101 Thomson Road, No. 20-04/05, United Square, Singapore, SGP, 307591
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.